Otitis externa, Chronic otitis media, and Acute otitis media
Conditions
Interventions
none
Sponsors
CEOLIA Pharma.Co.Ltd Pharmacovigilance Office
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients treated with this drug for otitis externa, chronic otitis media, and acute otitis media
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Examine the safety of the drug when administered under routine medical care. In conjunction, the efficacy of this drug also be examined. | — |
Contacts
Public ContactPharmacovigilance Office CEOLIA Pharma.Co.Ltd
CEOLIA Pharma.Co.Ltd
Outcome results
None listed